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Hepatitis A virus-HAV, He-
patitis B virus-HBV, Hepatitis D virus-HDV, Hepatitis C virus-HCV, Hepatitis E 
virus-HEV, Hepatitis G virus-HGV, Hepatitis F virus-HFV, Human imunode-
ficiency virus tip 1/2-HIV-1/2, Human T- cell lymphotropen virus I/II - HTLV I/II, 
Cytomegalovirus-CMV, Epstein-Bar virus-EBV, Human parvovirus B19 (B19V).
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 Yersinia enterocolitica).
Yersinia enterocolitica
C
E. coli, pseudomonas, citrobacter, Treponema 
pallidum, Borrelia burgdorferi, Brucela abortus, Salmonella, Yersinia entero-
colitica, Mycobacterium leprae, Rickettsia rickettsii.
Malaria, Chagas Leishmania, Tooplasmosis  Babesiosis  
Creutzfeldt-Jakob-
CJB)
(HCV, HBV, HGV, HIV-1/2, HTLV-1/2, MALARIA, SIFILIS, CMV, EBV, 
CHAGAS-
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              PREFACE 
 
 
 
 
 
 
In this book, a very important chapter of the transfusiology is worked out, 
which as a recent medical science seems to have a deficiency of appropriate and 
adeqate literature in Macedonian language. 
 A selection of the most frequent transfusiological transmissive diseases is 
made as a part of the transfusiology. Our experiences and the experiences of many 
world transfusiological, epidemiological and infectological centres are used. 
 In the last two decades the need of providing a safe therapy with blood, 
cell concentrates, plasma and plasma components caused a great interest in the 
scientific circles, since the transfunded patients are exposed on the possibility of 
receiving varios posttransfusion, transmissive infectious diseases of virus, bacterial 
and parasitic character. 
 The riskiest is transmission of viruses with blood transfusion since the 
donors-carriers of viruses seem clinicaly healthy and most frequently there are no 
data in their anamnesis of having virus disease. 
 In the book many viruses which cause virus transfusion transmissive 
diseases are included: Hepatitis A virus-HAV, Hepatitis B virus-HBV, Hepatitis D 
virus-HDV, Hepatitis C virus-HCV, Hepatitis E virus- -
HGV, Hepatitis F virus-HFV, Human imunodeficiency virus type 1/2-HIV-1/2, 
Human T-cell lymphotropen virus I/II-HTLV I/II, Cytomegalovirus CMV, 
Epstein-Bar virus EBV, Human parvovirus B19(B19V). These viruses meet the 
criteria of transmission: the agent is present in the blood, they give occasion of 
asymptomatic infections and they are stable in the blood and blood products in the 
conditions in which they are kept. 
 Bacterial contamination of the blood products may be the result of skin 
bacterium entered during the venepuction of the blood donors; during the 
processing of the blood in the apparatus, manipulation with the blood products 
from the transfusiological department to the departments where they are 
transfunded or of existence of bacteriemia which is asymptomatic at the donor 
during donating of the blood (for example Yersinia entericolitica). The number of 
contagious bacterium is growing with keeping of the cell concentrates or the 
plasma before they are transfunded. Keeping at room-temperature is increasing the 
growing of a great number of pathogenic bacterium. There are bacterium (e.g. 
Yersinia enterocolitica) which are quickly multiplied at the temperature of storing  
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the blood which is 40C. Gram negative, gram positive and diphteroid bacterium can 
cause transfusion associated acute sepsis (E.coli, pseudomonas, citrobacter, 
Treponema pallidum, Barrelia burgdorferi, Brucela abortus, Salmonella, Yersinia 
enterocolitica, Mycobacterium leprae, Rickettsia rickettsii. 
 Parasitic contamination of the blood may be noticed only if the blood 
donor has a parasitemia blood. Selection of the blood donors and the criteria which 
are based on anamnesis for the recent travellings staying abroad especially in the 
endemic regions, will reduce the possibility of transmitting of Malaria, Chagas-
disease, Lishmania, Tohoplasmosis and Babesiosis, Creutzfedt-Jakov disease-CJB 
is shown of the prion diseases as a possible transfusion transmissive disease. 
 At the description of these diseases, the transmission through blood, cell 
concentrates and plasma products is especially emphasised, as well as the way of 
serological diagnosing and detection of certain antibodies and antigens. 
 We tried to propose several recommendations which may be used for 
reduction of the risks of the transfusion of blood and blood components. The basic 
are: introducing the blood donor selection; obligatory testing of the blood of 
transmissive diseases (HCV, HBV, HGV, HIV-1/2, HTLV- 
SIFILIS, CMV, EBV, CHAGAS-disease and other transmissive diseases); strict 
indications and reduction of transfusions to the most necessary minimum or using 
pharmacological substituents; inactivation of viruses and bacterium in the whole 
blood, cell concentrates and plasma products; giving National strategy for safe 
transfusion of blood and blood products. 
 In future other infectious agents will probably appear which will question 
the safety of the blood. That's why the Department of Transfusiology has to raise 
the level and quality of its services and to offer safe blood transfusion in next years. 
 This book is first intended for doctors: transfusiologists, infectologists, 
epidemiologists, anesthesiologist, for the clinical doctors who state indications for 
blood transfusion, for students of medicine and other medical personnel and 
collaborators. Some lacks in the book are possible but they will be easily filled in 
and the mistakes will be easily corrected if they exist. We think that the book will 
justify its aim: to serve as a base for addition of the existing literature written by 
our professors, and at the same time will motivate for future writing. 
 We would like to thank d-r Jordanka Vitlarova, spec. transfusiologist who 
help in the realization of this book, prof. Kiril Panajotov for the language 
correction of the text and prof. 
texts. 
 Special thanks to our reviewers prof. d-r Nikola Siljanovski and d-r sci. 
med. Milenka Blagoevska, scientific professional collaborator. 
 
Translation: prof. Jordanka Veresa 
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